Clinical Trials Sponsored by Action Cancer

Total 69243 results

Actelion

Completed

PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial (PORTICO)

Portopulmonary Hypertension

United States, France, Germany, United Kingdom, Brazil, Czechia, Spain
Actelion

Terminated

Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) (OPTIMA)

Pulmonary Arterial Hypertension

France
Actelion

Completed

Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH

Pulmonary Arterial Hypertension

Spain, France, Italy
Actelion

Completed

Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, Germany
Actelion

Terminated

Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument (SYMPHONYext)

Pulmonary Arterial Hypertension

United States
Actelion

Completed

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Clostridium Difficile Infection

United States, Belgium, Israel, Argentina, Brazil, Canada, Chile, Croatia, Czechia, Greece, Hungary, Korea, Republic of, Romania, Slovakia
Actelion

Terminated

A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain (ORCHESTRA)

Pulmonary Arterial Hypertension

Spain, France, Italy
Actelion

Terminated

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

Glioblastoma

United States
Actelion

Completed

Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics

Healthy Subjects

Germany
Actelion

Completed

Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects

Healthy Subjects

Germany
Actelion

Completed

Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension (FUTURE 3)

Pulmonary Arterial Hypertension

United States, Australia, Belarus, China, Czechia, France, Germany, Hungary, India, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine
Actelion

Completed

Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)

Clostridium Difficile Infection

United States, Canada, Germany, Italy, Sweden, United Kingdom
Actelion

Completed

Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects

Healthy Subjects

France
Actelion

Completed

Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects

Healthy Subjects

France
Actelion

Completed

BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Pulmonary Arterial Hypertension

Canada, United Kingdom, Italy, United States, Netherlands, Australia, Austria, Belgium, France, Germany, Spain
Actelion

Completed

Bosentan in Children With Pulmonary Arterial Hypertension (FUTURE-1)

Pulmonary Arterial Hypertension

United States, France, Netherlands, Italy, Germany, Switzerland, United Kingdom
Actelion

Completed

Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults

Healthy Subjects

Czech Republic
Actelion

Terminated

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States, Spain, France
Actelion

Completed

Iloprost Power 15 in Pulmonary Arterial Hypertension (PROWESS 15)

Pulmonary Arterial Hypertension

United States, Austria, Germany
Actelion

Completed

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 (BUILD OL)

Idiopathic Pulmonary Fibrosis

United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
Actelion

Completed

BUILD 3: Bosentan Use in Interstitial Lung Disease (BUILD 3)

Idiopathic Pulmonary Fibrosis

United States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
Actelion

Terminated

Ventavis® Registry Protocol (RESPIRE)

Pulmonary Arterial Hypertension

United States
Actelion

Completed

Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®

Diarrhea

Canada
Actelion

Completed

Mass Balance, Pharmacokinetics, and Metabolism of 14C-labeled ACT-128800 Administered to Healthy Male Subjects

Pharmacokinetics

Switzerland
Actelion

Completed

Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study (MUSIC)

Idiopathic Pulmonary Fibrosis

United States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
Actelion

Completed

Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

Healthy

Germany
Actelion

Completed

Bosentan in Systemic Sclerosis (HOME)

Systemic Sclerosis | Digital Ulcers

Netherlands
Actelion

Completed

Digital Ulceration (CAP)

Systemic Sclerosis | Digital Ulcers

Belgium, Spain, United Kingdom, Germany, Italy, Portugal, France, Israel, Netherlands, Turkey, Austria, Switzerland, Greece, Czech Republic, Norway
Actelion

Terminated

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension (INHALE-15)

Pulmonary Arterial Hypertension

United States
Actelion

Completed

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (BENEFIT OL)

Pulmonary Hypertension

United States, Canada, Australia, Germany, Italy, United Kingdom, France, Austria, Belgium, Czech Republic, Netherlands, Poland, Spain
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis (BUILD 1)

Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
Actelion

Terminated

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) (ASSET-2)

Pulmonary Hypertension

United States, France, United Kingdom, Netherlands
Actelion

Completed

Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension | Pulmonary Hypertension | Ayerza Syndrome

United States
Actelion

Completed

Miglustat in Niemann-Pick Type C Disease

Niemann-Pick Type C Disease

United States
Actelion

Terminated

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Hypertension

United States, France, United Kingdom, Netherlands
Actelion

Completed

The Effect of Tracleer® on Male Fertility

Hypertension, Pulmonary

United States, Australia, Brazil, Czech Republic, Hungary
University of Ulster
Western Health and Social Care Trust; Action Cancer

Unknown

Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy

Colorectal Cancer

United Kingdom
ACTEON Group
Slb Pharma

Completed

Postoperative Pain After Root Canal Obturation With Sealer Containing Prednisolone.

Root Canal Obturation

France
Astion Pharma A/S

Completed

Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis

Seborrheic Dermatitis
Astion Pharma A/S

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

Discoid Lupus Erythematosus

Denmark
Astion Pharma A/S

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions

Discoid Lupus Erythematosus

Sweden
ACTEON Group
Slb Pharma

Completed

Efficacy of a Collagen Hemostatic Dressing After Tooth Extraction

Tooth Avulsion

France
ACTEON Group
Slb Pharma

Completed

Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone

Root Canal Obturation

France
Community Health Center, Inc.
Yale University; Innovations for Poverty Action

Completed

In It To Quit: Commitment Contracts for Smoking Cessation (I2Q)

Smoking

United States
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
St Stephens Aids Trust
Action Medical Research

Unknown

Progesterone and Aminophylline for the Prevention of Preterm Labour (PROGRAM)

Premature Obstetric Labor

United Kingdom
Action Contre la Faim
Johns Hopkins University

Unknown

Effectiveness of Safe Drinking Water in Treatment of Severe Acute Malnutrition (Pakistan)

Marasmus
Alliance for International Medical Action
European Commission

Completed

Evaluation of Two Community Based Screening Strategies for Severe Acute Malnutrition in Children 6-59 Months in Mirria District, Niger (MàLÉ)

Malnutrition

Niger
University of Chicago
Innovations for Poverty Action

Recruiting

Testing Response Bias on Sensitive Topics in Self- Versus Enumerator-administered Surveys

Bias, Implicit

Colombia
Assistance Publique - Hôpitaux de Paris
Action, France

Unknown

Impact of COVID19 Outbreak in Cardiac Acute Care (CCU-COVID19)

Heart Failure | Acute Coronary Syndrome | COVID

France

Clinical Trials Sponsored by Action Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations